DAFNA Capital Management as of Sept. 30, 2024
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 84 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Etf (XBI) | 9.4 | $40M | 402k | 98.80 | |
| Stereotaxis Com New (STXS) | 6.6 | $28M | 14M | 2.04 | |
| Revolution Medicines (RVMD) | 5.5 | $24M | 518k | 45.35 | |
| Cytokinetics Com New (CYTK) | 5.0 | $21M | 398k | 52.80 | |
| Merus N V (MRUS) | 4.9 | $21M | 413k | 49.96 | |
| AtriCure (ATRC) | 4.3 | $18M | 642k | 28.04 | |
| Ideaya Biosciences (IDYA) | 3.5 | $15M | 471k | 31.68 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.5 | $15M | 103k | 145.60 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.2 | $13M | 90k | 149.31 | |
| Axogen (AXGN) | 3.1 | $13M | 936k | 14.02 | |
| Blueprint Medicines (BPMC) | 2.7 | $11M | 122k | 92.50 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $11M | 274k | 39.37 | |
| Day One Biopharmaceuticals I (DAWN) | 2.5 | $11M | 750k | 13.93 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $10M | 527k | 19.25 | |
| Biohaven (BHVN) | 2.2 | $9.4M | 187k | 49.97 | |
| Tandem Diabetes Care Com New (TNDM) | 2.0 | $8.7M | 204k | 42.41 | |
| Kalvista Pharmaceuticals (KALV) | 2.0 | $8.4M | 724k | 11.58 | |
| Neurocrine Biosciences (NBIX) | 1.9 | $8.0M | 70k | 115.22 | |
| Kura Oncology (KURA) | 1.9 | $8.0M | 408k | 19.54 | |
| Viking Therapeutics (VKTX) | 1.9 | $8.0M | 126k | 63.31 | |
| Edgewise Therapeutics (EWTX) | 1.4 | $6.1M | 228k | 26.69 | |
| Urogen Pharma (URGN) | 1.4 | $5.8M | 459k | 12.70 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $5.1M | 667k | 7.60 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.1 | $4.7M | 4.0M | 1.17 | |
| Dex (DXCM) | 1.0 | $4.4M | 66k | 67.04 | |
| Keros Therapeutics (KROS) | 1.0 | $4.3M | 74k | 58.07 | |
| Alector (ALEC) | 1.0 | $4.3M | 913k | 4.66 | |
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $3.9M | 257k | 15.29 | |
| Galapagos Nv Spon Adr (GLPG) | 0.9 | $3.7M | 130k | 28.79 | |
| Insulet Corporation (PODD) | 0.9 | $3.7M | 16k | 232.75 | |
| Alkermes SHS (ALKS) | 0.8 | $3.4M | 121k | 27.99 | |
| Larimar Therapeutics (LRMR) | 0.8 | $3.2M | 494k | 6.55 | |
| Perspective Therapeutics Com New (CATX) | 0.7 | $3.1M | 230k | 13.35 | |
| 2seventy Bio Common Stock (TSVT) | 0.7 | $3.0M | 630k | 4.72 | |
| Acelyrin (SLRN) | 0.7 | $3.0M | 603k | 4.93 | |
| Allogene Therapeutics (ALLO) | 0.7 | $2.9M | 1.1M | 2.80 | |
| Aquestive Therapeutics (AQST) | 0.7 | $2.9M | 590k | 4.98 | |
| Century Therapeutics (IPSC) | 0.7 | $2.9M | 1.7M | 1.71 | |
| Astria Therapeutics (ATXS) | 0.7 | $2.8M | 254k | 11.01 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $2.8M | 122k | 22.63 | |
| Stoke Therapeutics (STOK) | 0.6 | $2.5M | 207k | 12.29 | |
| Brainsway Sponsored Ads (BWAY) | 0.5 | $2.3M | 251k | 9.24 | |
| Lexeo Therapeutics (LXEO) | 0.5 | $2.3M | 251k | 9.04 | |
| Accuray Incorporated (ARAY) | 0.5 | $2.2M | 1.2M | 1.80 | |
| Silverback Therapeutics (SPRY) | 0.5 | $2.2M | 148k | 14.50 | |
| Inogen (INGN) | 0.5 | $2.0M | 209k | 9.70 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $1.9M | 120k | 15.99 | |
| Mineralys Therapeutics (MLYS) | 0.4 | $1.8M | 147k | 12.11 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $1.8M | 487k | 3.63 | |
| Immatics Nv SHS (IMTX) | 0.4 | $1.7M | 145k | 11.41 | |
| Iteos Therapeutics (ITOS) | 0.4 | $1.6M | 162k | 10.21 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.4 | $1.6M | 906k | 1.82 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.4 | $1.5M | 243k | 6.30 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $1.5M | 34k | 43.89 | |
| Immunovant (IMVT) | 0.4 | $1.5M | 52k | 28.51 | |
| Regulus Therapeutics (RGLS) | 0.3 | $1.4M | 895k | 1.57 | |
| Gossamer Bio (GOSS) | 0.3 | $1.4M | 1.4M | 0.99 | |
| Lineage Cell Therapeutics In (LCTX) | 0.3 | $1.2M | 1.4M | 0.91 | |
| Mediwound Shs New (MDWD) | 0.3 | $1.2M | 65k | 18.06 | |
| Sutro Biopharma (STRO) | 0.3 | $1.1M | 330k | 3.46 | |
| Polypid (PYPD) | 0.3 | $1.1M | 309k | 3.44 | |
| Nyxoah S A SHS (NYXH) | 0.2 | $1.0M | 108k | 9.55 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $1.0M | 8.5k | 118.77 | |
| Adicet Bio (ACET) | 0.2 | $864k | 600k | 1.44 | |
| Compugen Ord (CGEN) | 0.2 | $809k | 447k | 1.81 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.2 | $787k | 112k | 7.00 | |
| Sage Therapeutics (SAGE) | 0.2 | $781k | 108k | 7.22 | |
| Grail (GRAL) | 0.2 | $672k | 49k | 13.76 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $643k | 204k | 3.15 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $544k | 125k | 4.35 | |
| Tourmaline Bio (TRML) | 0.1 | $491k | 19k | 25.71 | |
| Biomx Com New | 0.1 | $409k | 401k | 1.02 | |
| Masimo Corporation (MASI) | 0.1 | $400k | 3.0k | 133.33 | |
| Verastem Com New (VSTM) | 0.1 | $382k | 128k | 2.99 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $377k | 137k | 2.75 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $351k | 38k | 9.31 | |
| Neurogene (NGNE) | 0.1 | $326k | 7.8k | 41.96 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $324k | 341k | 0.95 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $306k | 27k | 11.44 | |
| Neuronetics (STIM) | 0.1 | $238k | 314k | 0.76 | |
| Compass Therapeutics (CMPX) | 0.1 | $215k | 117k | 1.84 | |
| Nevro (NVRO) | 0.1 | $212k | 38k | 5.59 | |
| Spero Therapeutics (SPRO) | 0.0 | $168k | 125k | 1.34 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $160k | 193k | 0.83 |
